| miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer J Sun, X Cai, MMH Yung, W Zhou, J Li, Y Zhang, Z Li, SS Liu, ... Oncogene 38 (4), 564-580, 2019 | 125 | 2019 |
| DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer Y Meng, CW Chen, MMH Yung, W Sun, J Sun, Z Li, J Li, Z Li, W Zhou, ... Cancer letters 428, 104-116, 2018 | 65 | 2018 |
| Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review T Li, T Huang, C Guo, A Wang, X Shi, X Mo, Q Lu, J Sun, T Hui, G Tian, ... The Innovation 2 (2), 2021 | 58 | 2021 |
| Erianin inhibits the proliferation of T47D cells by inhibiting cell cycles, inducing apoptosis and suppressing migration J Sun, X Fu, Y Wang, Y Liu, Y Zhang, T Hao, X Hu American journal of translational research 8 (7), 3077, 2016 | 57 | 2016 |
| Dendrobium candidum inhibits MCF-7 cells proliferation by inducing cell cycle arrest at G2/M phase and regulating key biomarkers J Sun, Y Guo, X Fu, Y Wang, Y Liu, B Huo, J Sheng, X Hu OncoTargets and therapy, 21-30, 2015 | 53 | 2015 |
| DHS (trans−4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2) CW Chen, Y Li, S Hu, W Zhou, Y Meng, Z Li, Y Zhang, J Sun, Z Bo, ... Oncogene 38 (13), 2364-2379, 2019 | 46 | 2019 |
| Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice J Sun, X Fu, Y Liu, Y Wang, B Huo, Y Guo, X Gao, W Li, X Hu Drug design, development and therapy, 6327-6342, 2015 | 42 | 2015 |
| ERK regulates HIF1α-mediated platinum resistance by directly targeting PHD2 in ovarian cancer Z Li, W Zhou, Y Zhang, W Sun, MMH Yung, J Sun, J Li, CW Chen, Z Li, ... Clinical Cancer Research 25 (19), 5947-5960, 2019 | 39 | 2019 |
| Magnolia officinalis extract contains potent inhibitors against PTP1B and attenuates hyperglycemia in db/db mice J Sun, Y Wang, X Fu, Y Chen, D Wang, W Li, S Xing, G Li BioMed Research International 2015, 2015 | 30 | 2015 |
| The Cdk2–c-Myc–miR-571 axis regulates DNA replication and genomic stability by targeting geminin Y Zhang, Z Li, Q Hao, W Tan, J Sun, J Li, C Chen, Z Li, Y Meng, Y Zhou, ... Cancer research 79 (19), 4896-4910, 2019 | 28 | 2019 |
| Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation Y Guo, X Fu, Y Jin, J Sun, Y Liu, B Huo, X Li, X Hu Drug design, development and therapy, 3153-3162, 2015 | 25 | 2015 |
| Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis K Le, J Sun, H Khawaja, M Shibata, SB Maggirwar, MR Smith, M Gupta Blood Advances 5 (14), 2863-2878, 2021 | 21 | 2021 |
| GATA2 regulates GATA1 expression through LSD1-mediated histone modification Y Guo, X Fu, B Huo, Y Wang, J Sun, L Meng, T Hao, ZJ Zhao, X Hu American journal of translational research 8 (5), 2265, 2016 | 21 | 2016 |
| SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance J Li, R Wu, MMH Yung, J Sun, Z Li, H Yang, Y Zhang, SS Liu, ... Cell Death & Disease 12 (4), 341, 2021 | 17 | 2021 |
| Inhibition of HMGB1 overcomes resistance to radiation and chemotherapy in nasopharyngeal carcinoma X Zhu, J Cong, Z Lin, J Sun, B Yang, A Li OncoTargets and therapy, 4189-4199, 2020 | 14 | 2020 |
| PAXX participates in base excision repair via interacting with Pol β and Contributes to TMZ resistance in glioma cells B Yang, X Fu, J Hao, J Sun, Z Li, H Li, H Xu Journal of Molecular Neuroscience 66, 214-221, 2018 | 12 | 2018 |
| Discovery and characterization of potent And‐1 inhibitors for cancer treatment J Li, Y Zhang, J Sun, L Chen, W Gou, CW Chen, Y Zhou, Z Li, DW Chan, ... Clinical and translational medicine 11 (12), e627, 2021 | 7 | 2021 |
| Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b C Demosthenous, SK Gupta, J Sun, Y Wang, TP Troska, M Gupta Frontiers in Oncology 10, 1226, 2020 | 7 | 2020 |
| Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer Z Liu, M Yu, B Fei, J Sun, D Wang OncoTargets and therapy, 2095-2104, 2019 | 7 | 2019 |
| CtIP contributes to non-homologous end joining formation through interacting with ligase IV and promotion of TMZ resistance in glioma cells. B Yang, N Han, J Sun, H Jiang, HY Xu European Review for Medical & Pharmacological Sciences 23 (5), 2019 | 7 | 2019 |
